ACADM and B-cell chronic lymphocytic leukemia: In CLL proteomics, a plethora of proteins involved in metabolism were found increased (e.g., GAPDH, GLUT2, NAXE, COX 6B, CPT2, GRPEL1, PKM, FABP3, IDH2, ACADM, ACAA2, CPT2), which could be considered as novel therapeutic targets alone or in combination with other targets.